This paper aims at analysing the main features of R&D activities carried out by the Italian biotech companies. The proposed contribution can be ascribed to the massive stream of research related to the reconfiguration of the value chain activities at the international level. Such a topic has...

This paper aims at analysing the main features of the activities carried out by the Italian biotech industry. This topic is so wide and various that particularly we decided to focus on the value added activities of the so-called “pharma-biotech”, i.e. pharmaceutical firms that have...

Over the past five years, use of the term “back-shoring” (and of its apparent synonyms) has multiplied dramatically, especially in economics journalism and in consulting firms’ white papers. More recently, the topic has prompted academic investigation too, despite the lack of reliable...

The foreign development of high-tech start-ups is an important issue, since international activity requires specific knowledge that new firms may find it difficult to locate and acquire. It has been found that the pattern of foreign development in high-tech start-ups differs from that of...

This paper aims at analyzing the main features of Research and Development (R&D) activities carried out by the Italian biotech companies. It was decided to focus on the biotech industry, because of the specific features of its knowledge firms (Kamath, 2007), that deeply influence both the...

The paper is focused on a phenomenon – the so called “back-shoring” (often indicated also as “onshoring”, “in-shoring”, “re-shoring”, “reverse-shoring”, “international re-concentration”, “reverse-globalization”, even if they are not always considered synonymous) –...

Over the past years, use of the terms like “on-shoring”, “re-shoring” and “back-shoring” has multiplied dramatically, especially in economics journalism and in consulting firms’ white papers. More recently, the topic has also attracted academic attention. Notwithstanding this...